Mathew H. .2017 ."Adipose tissue and reproductive health." Metabolism: Clinical and Experimental. , 11 : 18-32.
Hariharan R. .2022 ."The dietary inflammatory index, obesity, type 2 diabetes and cardiovascular risk factors and diseases. " Obesity Reviews, 23(1) : .
Boutari C.,Mantzoros C.S. .2022 ."A 2022 update on the epidemiology of obesity and a call to action: As its twin COVID-19 Pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on." Metabolism: Clinical and Experimental. , 155217 : .
Sindhwani R. . ."The dual challenge of diabesity: pathophysiology, management and future directions." NaunynSchmiedeberg's Archives of Pharmacology. , 398(2025) : 4891-4912.
Kloock S. .2023 ."Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery?" Pharmacology and Therapeutics. , 108549 : .
Kheniser K. . ."Long-Term weight loss strategies for obesity.". The Journal of Clinical Endocrinology & Metabolism, 106(2021) : 1854-1866.
Jalleh R.J. . ."Clinical consequences of delayed gastric emptying with GLP-1 receptor agonists and tirzepatide.". The Journal of Clinical Endocrinology & Metabolism, 110(2024) : 1-15.
Rubio-Herrera M. .2023 ."Impact of treatment with GLP-1 receptor agonists, liraglutide 3.0 mg and semaglutide 1.0 mg, while on a waiting list for bariatric surgery. " Biomedicines, 2785(10) : .
Alyassi A. .2024 ."GLP-1 receptor agonists as a breakthrough therapy for obesity and metabolic syndrome: A systematic review of efficacy and long-term outcomes. " Journal of Population Therapeutics and Clinical Pharmacology, 31(11) : 1915-1925.
Blüher M. . ."New insights into the treatment of obesity. " Diabetes, Obesity and Metabolism, 25(2023) : 2058-2072.
Oppert J.M. .2021 ."Exercise training in the management of overweight and obesity in adults: Synthesis of the evidence and recommendations from the European association for the study of obesity physical activity working group. " Obesity Reviews, 22(suppl) : .
Jensen S.B.K. .2024 ."Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: A post-treatment analysis of a randomised placebo-controlled trial. " EClinicalMedicine, 102475 : .
Sandsdal R.M. .2023 ."Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity and inflammation: A randomized controlled trial. " Cardiovascular Diabetology, 41(1) : .
Jensen S.B.K. .2022 ."Exploratory analysis of eating- and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise and liraglutide single or combination treatment.". Nature Communications, 4770(1) : .
Mensberg P. . ."Near-normalization of glycaemic control with glucagon-like peptide-1 receptor agonist treatment combined with exercise in patients with type 2 diabetes." Diabetes, Obesity and Metabolism. , 19(2017) : 172-180.
Lundgren J.R. .2021 ."Healthy weight loss maintenance with exercise, liraglutide, or both combined.". The New England Journal of Medicine, 384(18) : 1719-1730.
Jensen S.B.K. . ."Weight loss maintenance with exercise and liraglutide improves glucose tolerance, glucagon response and beta cell function. " Obesity, 31(2023) : 977-989.
Wadden T.A. . ."Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for obesity in primary care: The SCALE IBT randomized controlled trial. " Obesity, 28(2020) : 529-536.
Choi G.J. and H.,Kang G.J. and H. . ."Heterogeneity in meta-analyses: An unavoidable challenge worth exploring.". Korean Journal of Anesthesiology, 78(2025) : 301-314.
Khera R. .2016 ."Association of pharmacological treatments for obesity with weight loss and adverse events: A systematic review and meta-analysis. " JAMA, 7602(22) : 2424-2434.
Swift D.L. .2013 ."The role of exercise and physical activity in weight loss and maintenance." Progress in Cardiovascular Diseases. , 09(2014) : 441-447.
Rosenbaum M.,Leibel R.L. .2010 ."Adaptive thermogenesis in humans.". International Journal of Obesity, 184(2010) : S47-S55.
Moiz A. .2025 ."Mechanisms of GLP-1 receptor agonistinduced weight loss: A review of central and peripheral pathways in appetite and energy regulation. " The American Journal of Medicine, 01(2025) : 934-940.
Małkowska P. . ."Positive effects of physical activity on insulin signaling." Current Issues in Molecular Biology. , 46(2024) : 5467-5487.
Cava E. . ."Preserving healthy muscle during weight loss." Advances in Nutrition. , 8(2017) : 511-519.
Ross R. . ."Waist circumference as a vital sign in clinical practice: A Consensus statement from the IAS and ICCR working group on visceral obesity." Nature Reviews Endocrinology. , 16(2020) : 177-189.
Zhao X. .2023 ."The crucial role and mechanism of insulin resistance in metabolic disease." Frontiers in Endocrinology. , 1149239 : .
Liu J. . ."Liraglutide and exercise synergistically attenuate vascular inflammation and enhance metabolic insulin action in early diet-induced obesity. " Diabetes, 72(2023) : 0745-931.